First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile.
udgivet i: Investigational New Drugs
dato for udgivelse: 2017-08-12
Cites articles 51
- 2009-01-01
- 2009-01-01
- 2009-04-28
Date
Titel
Artikel - wd:Q48238685